dacarbazine has been researched along with lactoferrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aalberti, S; Arcella, A; Bartolo, M; Cantore, G; Frati, A; Giangaspero, F; Grillea, G; Madonna, M; Oliva, MA; Pavone, L; Staffieri, S | 1 |
| Gao, Z; Lai, X; Mao, G; Xiao, X; Zhang, J; Zhu, J; Zhu, X | 1 |
| Bhattacharya, D; Chakarvarty, S; Kondapi, AK; Kumari, S; Rangaraj, N; Rao, NM | 1 |
3 other study(ies) available for dacarbazine and lactoferrin
| Article | Year |
|---|---|
In vitro and in vivo effect of human lactoferrin on glioblastoma growth.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; Dacarbazine; Drug Therapy, Combination; Glioblastoma; Humans; Lactoferrin; Male; Mice; Mice, Nude; Temozolomide; Tumor Cells, Cultured | 2015 |
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lactoferrin; Lipids; Mice, Inbred BALB C; Nanostructures; Neoplasms, Neuroepithelial; Oligopeptides; Temozolomide; Tissue Distribution; Vincristine; Xenograft Model Antitumor Assays | 2018 |
Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma.
Topics: Animals; Apoptosis; Aurora Kinase B; Blood-Brain Barrier; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Glioblastoma; Humans; Lactoferrin; Mice; RNA, Small Interfering; Temozolomide; Xenograft Model Antitumor Assays | 2018 |